Frank Xinhe Wu

Person

Shrewsbury, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Beta-lactamase inhibitor compounds
- Patent number 10,800,778
- Issue date Oct 13, 2020
- Entasis Therapeutics Limited
- Janelle Comita-Prevoir
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Metabotrophic glutamate receptor 5 modulators and methods use thereof
- Patent number 10,640,510
- Issue date May 5, 2020
- Sunovion Pharmaceuticals Inc.
- Michele L. R. Heffernan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Metabotrophic glutamate receptor 5 modulators and methods of use th...
- Patent number 10,533,000
- Issue date Jan 14, 2020
- Sunovion Pharmaceuticals, Inc.
- Michele L. R. Heffernan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Metabotrophic glutamate receptor 5 modulators and methods use thereof
- Patent number 10,196,399
- Issue date Feb 5, 2019
- Sunovion Pharmaceuticals Inc.
- Michele L. R. Heffernan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for treating disorders mediated by metabotropic glutamate...
- Patent number 10,077,243
- Issue date Sep 18, 2018
- Sunovion Pharmaceuticals Inc.
- Larry Wendell Hardy
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Metabotrophic glutamate receptor 5 modulators and methods of use th...
- Patent number 9,708,331
- Issue date Jul 18, 2017
- Sunovion Pharmaceuticals Inc.
- Michele L. R. Heffernan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Metabotrophic glutamate receptor 5 modulators and methods of use th...
- Patent number 9,260,452
- Issue date Feb 16, 2016
- Sunovion Pharmaceuticals Inc.
- Michele L. R. Heffernan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for treating disorders mediated by metabotropic glutamate...
- Patent number 8,772,301
- Issue date Jul 8, 2014
- Sunovion Pharmaceuticals, Inc.
- Larry Wendell Hardy
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Imidazo[1,2-a]pyridine compounds
- Patent number 8,497,278
- Issue date Jul 30, 2013
- Sunovion Pharmaceuticals Inc.
- Qun Kevin Fang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Macrocyclic hepatitis C serine protease inhibitors
- Patent number 8,124,584
- Issue date Feb 28, 2012
- Enanta Pharmaceuticals, Inc.
- Zhenwei Miao
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Macrocyclic hepatitis C serine protease inhibitors
- Patent number 7,601,709
- Issue date Oct 13, 2009
- Enanta Pharmaceuticals, Inc.
- Zhenwei Miao
- E05 - LOCKS KEYS WINDOW OR DOOR FITTINGS SAFES
Information Patent Grant
Cyclosporin derivatives for the treatment of immune disorders
- Patent number 7,468,419
- Issue date Dec 23, 2008
- Enanta Pharmaceuticals, Inc.
- Frank X. H. Wu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Aza-peptide macrocyclic hepatitis C serine protease inhibitors
- Patent number 7,125,845
- Issue date Oct 24, 2006
- Enanta Pharmaceuticals, Inc.
- Frank X. H. Wu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
METABOTROPHIC GLUTAMATE RECEPTOR 5 MODULATORS AND METHODS USE THEREOF
- Publication number 20200079778
- Publication date Mar 12, 2020
- SUNOVION PHARMACEUTICALS INC.
- Michele L. R. Heffernan
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BETA-LACTAMASE INHIBITOR COMPOUNDS
- Publication number 20190202832
- Publication date Jul 4, 2019
- Entasis Therapeutics Limited
- Gregory S. Basarab
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METABOTROPHIC GLUTAMATE RECEPTOR 5 MODULATORS AND METHODS USE THEREOF
- Publication number 20190135815
- Publication date May 9, 2019
- SUNOVION PHARMACEUTICALS INC.
- Michele L. R. Heffernan
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS FOR TREATING DISORDERS MEDIATED BY METABOTROPIC GLUTAMATE...
- Publication number 20190055204
- Publication date Feb 21, 2019
- Sunovion Pharmaceuticals Inc.
- Larry Wendell Hardy
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METABOTROPHIC GLUTAMATE RECEPTOR 5 MODULATORS AND METHODS USE THEREOF
- Publication number 20180037585
- Publication date Feb 8, 2018
- SUNOVION PHARMACEUTICALS INC.
- Michele L. R. Heffernan
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METABOTROPHIC GLUTAMATE RECEPTOR 5 MODULATORS AND METHODS OF USE TH...
- Publication number 20160251359
- Publication date Sep 1, 2016
- SUNOVION PHARMACEUTICALS INC.
- Michele L. R. Heffernan
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS FOR TREATING DISORDERS MEDIATED BY METABOTROPIC GLUTAMATE...
- Publication number 20140349992
- Publication date Nov 27, 2014
- SUNOVION PHARMACEUTICALS INC.
- Larry Wendell Hardy
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METABOTROPHIC GLUTAMATE RECEPTOR 5 MODULATORS AND METHODS OF USE TH...
- Publication number 20140221332
- Publication date Aug 7, 2014
- SUNOVION PHARMACEUTICALS INC.
- Michele L. R. Heffernan
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METABOTROPHIC GLUTAMATE RECEPTOR 5 MODULATORS AND METHODS OF USE TH...
- Publication number 20140179682
- Publication date Jun 26, 2014
- SUNOVION PHARMACEUTICALS INC.
- Michele L. R. Heffernan
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IMIDAZO[1,2-a]PYRIDINE COMPOUNDS
- Publication number 20130289013
- Publication date Oct 31, 2013
- Qun Kevin FANG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds for Treating Disorders Mediated by Metabotropic Glutamate...
- Publication number 20110319380
- Publication date Dec 29, 2011
- SUNOVION PHARMACEUTICALS INC.
- Larry Wendell Hardy
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IMIDAZO[1,2-a]PYRIDINE COMPOUNDS
- Publication number 20110166146
- Publication date Jul 7, 2011
- SUNOVION PHARMACEUTICALS INC.
- Qun Kevin Fang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MACROCYCLIC HEPATITIS C SERINE PROTEASE INHIBITORS
- Publication number 20090304629
- Publication date Dec 10, 2009
- Zhenwei Miao
- E05 - LOCKS KEYS WINDOW OR DOOR FITTINGS SAFES
Information Patent Application
Cyclosporin Derivatives for the Treatment of Immune Disorders
- Publication number 20070249527
- Publication date Oct 25, 2007
- Frank X. H. Wu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Aza-peptide macrocyclic hepatitis c serine protease inhibitors
- Publication number 20070021330
- Publication date Jan 25, 2007
- Enanta Pharmaceuticals, Inc.
- Frank Wu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Macrocyclic hepatitis C serine protease inhibitors
- Publication number 20050153877
- Publication date Jul 14, 2005
- Zhenwei Miao
- E05 - LOCKS KEYS WINDOW OR DOOR FITTINGS SAFES
Information Patent Application
Aza-peptide macrocyclic hepatitis C serine protease inhibitors
- Publication number 20050065073
- Publication date Mar 24, 2005
- Frank X. H. Wu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Cyclosporin derivatives for the treatment of immune disorders
- Publication number 20040266669
- Publication date Dec 30, 2004
- Frank X. H. Wu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Pyridazinonyl macrocyclic hepatitis C serine protease inhibitors
- Publication number 20040180815
- Publication date Sep 16, 2004
- Suanne Nakajima
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Frank Xinhe Wu

Person

Patents Grantslast 30 patents

Beta-lactamase inhibitor compounds

Metabotrophic glutamate receptor 5 modulators and methods use thereof

Metabotrophic glutamate receptor 5 modulators and methods of use th...

Metabotrophic glutamate receptor 5 modulators and methods use thereof

Compounds for treating disorders mediated by metabotropic glutamate...

Metabotrophic glutamate receptor 5 modulators and methods of use th...

Metabotrophic glutamate receptor 5 modulators and methods of use th...

Compounds for treating disorders mediated by metabotropic glutamate...

Imidazo[1,2-a]pyridine compounds

Macrocyclic hepatitis C serine protease inhibitors

Macrocyclic hepatitis C serine protease inhibitors

Cyclosporin derivatives for the treatment of immune disorders

Aza-peptide macrocyclic hepatitis C serine protease inhibitors

Patents Applicationslast 30 patents

METABOTROPHIC GLUTAMATE RECEPTOR 5 MODULATORS AND METHODS USE THEREOF

BETA-LACTAMASE INHIBITOR COMPOUNDS

METABOTROPHIC GLUTAMATE RECEPTOR 5 MODULATORS AND METHODS USE THEREOF

COMPOUNDS FOR TREATING DISORDERS MEDIATED BY METABOTROPIC GLUTAMATE...

METABOTROPHIC GLUTAMATE RECEPTOR 5 MODULATORS AND METHODS USE THEREOF

METABOTROPHIC GLUTAMATE RECEPTOR 5 MODULATORS AND METHODS OF USE TH...

COMPOUNDS FOR TREATING DISORDERS MEDIATED BY METABOTROPIC GLUTAMATE...

METABOTROPHIC GLUTAMATE RECEPTOR 5 MODULATORS AND METHODS OF USE TH...

METABOTROPHIC GLUTAMATE RECEPTOR 5 MODULATORS AND METHODS OF USE TH...

IMIDAZO[1,2-a]PYRIDINE COMPOUNDS

Compounds for Treating Disorders Mediated by Metabotropic Glutamate...

IMIDAZO[1,2-a]PYRIDINE COMPOUNDS

MACROCYCLIC HEPATITIS C SERINE PROTEASE INHIBITORS

Cyclosporin Derivatives for the Treatment of Immune Disorders

Aza-peptide macrocyclic hepatitis c serine protease inhibitors

Macrocyclic hepatitis C serine protease inhibitors

Aza-peptide macrocyclic hepatitis C serine protease inhibitors

Cyclosporin derivatives for the treatment of immune disorders

Pyridazinonyl macrocyclic hepatitis C serine protease inhibitors